ALIMTA Improves Survival In Non-Small Cell Lung Cancer
May 28, 2008 · Filed Under Cancer Treatment · Comment
The type of non-small cell lung cancer (NSCLC) patients have may now influence their treatment regimen and, in turn, survival outcome according to the results of a major study published online in the Journal of Clinical Oncology. Publication of the study was announced by Eli Lilly and Company. Read more

